Melatonin for heart muscle protection
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if adding melatonin to standard heart medication helps protect the heart muscle in people with cardiomyopathy. If you are stable on your current heart meds, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with a doctor-confirmed diagnosis of cardiomyopathy
- Your heart condition is stable while taking standard medications (like ACE inhibitors or beta-blockers)
- You have not been hospitalized for heart problems in the last 3 months
- You do not have severe kidney or liver disease
- You are not pregnant or planning to become pregnant in the next 6 months
- You have not taken melatonin before (and had an allergic reaction) and are not in another research study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding melatonin to standard heart failure treatment helps women with peripartum cardiomyopathy recover heart function and reduce inflammation. It may offer a simple, well-tolerated option to support heart healing after pregnancy.
This study tests whether taking a melatonin supplement every night for two years reduces the risk of heart problems and cancer in older adults. If you are generally healthy and between 60 and 74, you may be able to join.
This study tests whether melatonin can help improve heart health in midlife women with high blood pressure. It involves taking a melatonin pill or placebo for several weeks and checking blood pressure and other health markers.
This study tests whether taking 5 mg of melatonin can improve thinking and brain health over time in older adults with early, mild symptoms. You may help researchers learn which brain changes and measures improve with melatonin.
This Phase 2 study tests whether melatonin can improve sleep and possibly outcomes related to diabetic retinopathy (damage to the retina from diabetes). It also checks whether it affects related symptoms while keeping people safe.
This trial tests if adding melatonin can reduce oxidative stress (a kind of cell damage) in people with mild to moderate Parkinson's disease who are already taking levodopa. It aims to see if melatonin helps protect the brain and improve symptoms.
Hear when a new Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.